Contracts Finder · Award
Breast Cancer Oncotype Testing
A public procurement published by Lincolnshire Partnership NHS Foundation Trust via Contracts Finder.
- £490.1k
- Award value
- £490.1k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy. Additional information: Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85111800 — Pathology services
- Currency
- GBP
- Total award value
- £490,050
- Tender value
- £490,050
- First published
- 26 Apr 2024
- Last updated
- 26 Apr 2024
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Exact Sciences UK, Ltd. | 07484560 | 14 Apr 2024 | active | £490.1k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Lincolnshire Partnership NHS Foundation Trust
FAQs about this procurement
Who is the buyer for "Breast Cancer Oncotype Testing"?
Breast Cancer Oncotype Testing is a UK public-sector procurement published by Lincolnshire Partnership NHS Foundation Trust via Contracts Finder.
Has "Breast Cancer Oncotype Testing" been awarded?
Yes — 1 award is recorded, with a reported total value of £490,050. The current lifecycle stage is "Award".
Which suppliers are involved in "Breast Cancer Oncotype Testing"?
1 supplier is linked: Exact Sciences UK, Ltd..
What is "Breast Cancer Oncotype Testing" worth?
The reported award value is £490,050.
When was "Breast Cancer Oncotype Testing" published?
It was first published on 26 Apr 2024 and last updated on 26 Apr 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable